Q2 STOCKS TO BUY

Buzz Stocks: Apple Inc., Abercrombie & Fitch Co., and Orexigen Therapeutics, Inc.

Today's stocks to watch in the news include Apple Inc. (AAPL), Abercrombie & Fitch Co. (ANF), and Orexigen Therapeutics, Inc. (OREX)

Aug 30, 2016 at 9:44 AM
facebook X logo linkedin


Major indexes appear set to take a breather this morning after Monday's big Wall Street win. Among specific equities in focus are iPhone parent Apple Inc. (NASDAQ:AAPL), retail stock Abercrombie & Fitch Co. (NYSE:ANF), and biotech Orexigen Therapeutics, Inc. (NASDAQ:OREX).

  • AAPL is down 0.6% at $106.19, after the European Union (EU) said Apple Inc. could owe as much as $14.5 billion in back taxes after its tax arrangement with Ireland was found illegal -- a decision CEO Tim Cook said the company will appeal. The speculation first hit the Street yesterday, as rumors also swirled around the firm's upcoming Sept. 7 event -- where many expect the newest iteration of the iPhone may be revealed. The stock is now seated just above its year-to-date breakeven mark, and AAPL could be in more trouble if the overwhelming optimism among analysts should begin to unwind. At the moment, roughly 86% of brokerage firms tracking the stock rate it a "buy" or better.

  • ANF has plunged 17% at the open at $19.06, after the company reported its 14th consecutive quarterly drop in sales, with Executive Chairman Arthur Martinez saying the company expects "flagship and tourist locations will continue to weigh on business" for the remainder of the year. Traders had been betting on a significant post-earnings swing for the stock -- which was already off 18% year-to-date heading into today's trading -- and it appears most were hoping for a move to the downside. Not only have options traders been unusually put-skewed of late, but short interest also accounts for more than 21% of Abercrombie & Fitch Co.'s total float. At the stock's typical daily volume, it would take a full nine sessions to cover all these pessimistic positions.

  • OREX is 15.6% higher at $4.37, on news the company has signed an agreement with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to commercialize and distribute its obesity drug, Contrave, in Canada. An extended rally today would help Orexigen Therapeutics begin to win back some of its 75% year-to-date losses, with the shares fresh off a record low of $3.18, hit earlier this month. The shares have been running into tough resistance at their 20-week moving average of late -- a trendline they haven't topped on a closing basis since May 2015. Unsurprisingly, the underperformer hasn't seen much love on the Street, where all three analyst tracking OREX recommend a "hold" or "sell."

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter